Equity Components [Axis] Common Stock [Member] Additional Paid-In-Capital [Member] Accumulated Deficit Antidilutive Securities [Axis] Outstanding Options [Member] Outstanding Warrants [Member] Convertible Preferred Stock [Member] Class of Stock [Axis] Series A Convertible Preferred Stock [Member] Related Party [Axis] Investor [Member] Warrants [Member] Plan Name [Axis] 2015 Long-term Incentive Plan [Member] Award Type [Axis] Stock Options [Member] Award Date [Axis] 2020 [Member] 2021 [Member] Type of Arrangement and Non-arrangement Transactions [Axis] Exclusive License Agreement [Member] Title of Individual [Axis] Dr. Brent Satterfield [Member] Dr. Satterfield [Member] Convertible Preferred Stock [Member] Legal Entity [Axis] Two Companies [Member] Four Individuals [Member] Ten Employees and Two Member of Board of Directors [Member] Three Companies [Member] Professional Services Agreement [Member] 2022 [Member] Subsequent Event Type [Axis] Subsequent Event [Member] Common Stock [Member] Cover [Abstract] Entity Registrant Name Entity Central Index Key Document Type Document Period End Date Amendment Flag Current Fiscal Year End Date Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Entity Ex Transition Period Entity Shell Company Entity Common Stock, Shares Outstanding Document Fiscal Period Focus Document Fiscal Year Focus Statement of Financial Position [Abstract] ASSETS: Current Assets Cash and cash equivalents Accounts receivables, net Inventory Prepaid expenses Total current assets Other Assets Property and equipment, net Investment in joint venture Total other assets Total assets LIABILITIES AND STOCKHOLDERS' EQUITY: Current Liabilities Accounts payable Accrued expenses Accrued expenses (related party) Deferred revenue Total current liabilities Long-term Liabilities, net of current portion Accrued expenses-long-term (related party) Total long-term liabilities, net of current portion Total liabilities STOCKHOLDERS' EQUITY Convertible preferred stock, $0.001 par value; 5,000,000 shares authorized, 0 and 25,600 shares issued and outstanding as of June 30, 2020 and December 31, 2019, respectively Common stock, $0.001 par value, 100,000,000 shares authorized; 27,991,042 and 17,342,922 shares issued and outstanding, as of June 30, 2020 and December 31, 2019, respectively. Additional paid-in capital Accumulated deficit Total stockholders' equity Total liabilities and stockholders' equity Convertible preferred stock, par value Convertible preferred stock , shares authorized Convertible preferred stock, shares issued Convertible preferred stock, shares outstanding Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Income Statement [Abstract] Net revenue Cost of revenue Gross profit Operating expenses: Sales and marketing Administrative and general Research and development Depreciation and amortization Total operating expenses Income (loss) from operations Other expense: Interest income Interest expense Gain on disposition of assets Gain (loss) on equity method investment in joint venture Total other expense Income (loss) before income taxes Provision for income taxes Net income (loss) Basic income (loss) per common share Diluted income (loss) per common share Weighted average common shares outstanding basic Weighted average common shares outstanding diluted Statement of Cash Flows [Abstract] Cash flows from operating activities: Net income (loss) Adjustments to reconcile net income (loss) to net cash used in operating activities: Stock based compensation Accretion of notes payable discount Gain on disposition of assets Loss (gain) of equity method investment Changes in assets and liabilities: Increase in accounts and other receivables Increase in prepaid and other assets Decrease (increase) in inventory Increase in deferred revenue Increase (decrease) in accounts payable and accrued expenses Net cash used in operating activities Cash flows from investing activities: Purchase of property and equipment Investment in joint venture Net cash used in investing activities Cash flows from financing activities: Proceeds from sale of common stock Proceeds from sale of preferred stock Proceeds from exercise of options and warrants Payment of offering costs Net cash provided by financing activities Net increase in cash Cash and cash equivalents beginning of period Cash and cash equivalents end of period Supplemental disclosure of cash flow information: Interest paid Income taxes paid Supplemental disclosure of non-cash investing and financing transactions: Inventory moved to property, plant and equipment Statement [Table] Statement [Line Items] Beginning balance Beginning balance, shares Public Offering, net of offering costs Public Offering, net of offering costs, shares Issuance of Common Stock for warrant exercises Issuance of Common Stock for warrant exercises, shares Issuance of Common Stock for option and warrant exercises Issuance of Common Stock for option and warrant exercises, shares Stock-based compensation expense Stock-based compensation expense, shares Issuance of common stock for services Issuance of common stock for services, shares Conversion of Preferred Stock to Common Conversion of Preferred Stock to Common, shares Issuance of Preferred Stock Issuance of Preferred Stock, shares Net loss Ending balance Ending balance, shares Statement of Stockholders' Equity [Abstract] Public offering costs Accounting Policies [Abstract] Overview and Basis of Presentation Summary of Significant Accounting Policies Equity [Abstract] Equity Share-based Payment Arrangement, Disclosure [Abstract] Stock-Based Compensation Related Party Transactions [Abstract] Related Party Transactions Leases [Abstract] Lease Obligations Subsequent Events [Abstract] Subsequent Events Accounts Receivable Equity-Method Investments Inventory Revenue Recognition Earnings (Loss) Per Share Research and Development Recent Accounting Pronouncements Commitments and Contingency Schedule of Fair Value of Options Weighted Average Assumptions Schedule of Option Activity Schedule of Warrant Activity Schedule of Unrecognized Stock-based Compensation Schedule of Ongoing Lease Obligation Accounts receivable Doubtful accounts Accounts receivable, net Inventory finished goods Inventory raw materials Potentially dilutive shares Research and development cost Schedule of Stock by Class [Table] Class of Stock [Line Items] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Number of common stock issued Sale of common stock purchase price per shares Issuance of common stock gross proceeds Net proceeds from issuance of common stock Offering costs Number of common stock issued, value Stock issued during period, warrant exercised value Warrants exercisable price per share Number of conversion of shares issued Conversion of preferred stock Conversion of preferred stock, price per shares Number of warrants exercised Number of shares issued for services Value of shares issued for services Proceeds from warrants exercise Proceeds from stock option exercised Number of stock option exercised Purchase price Promissory note Equity ownership percentage Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Aggregate number of common shares reserved Unissued common stock options authorized shares Intrinsic value of options outstanding Unvested option shares outstanding Intrinsic value of options and warrants exercised Unrecognized stock-based compensation Share-based Payment Arrangement [Abstract] Risk free interest rate Expected life (in years) Expected volatility Expected dividend yield Stock price Options Outstanding, Beginning Options Outstanding, Option granted Options Outstanding, Expired Options Outstanding, Forfeited options Options Outstanding, Exercised Options Outstanding, Ending Weighted Average Exercise Price Outstanding, Beginning Weighted Average Exercise Price Options granted Weighted Average Exercise Price Expired Weighted Average Exercise Price Forfeited options Weighted Average Exercise Price Exercised Weighted Average Exercise Price Outstanding, Ending Weighted Average Fair Value Outstanding, Beginning Weighted Average Fair Value Options granted Weighted Average Fair Value Expired Weighted Average Fair Value Forfeited options Weighted Average Fair Value Exercised Weighted Average Fair Value Outstanding, Ending Weighted-average Remaining Contractual Life (years) Outstanding, Beginning Weighted-average Remaining Contractual Life (years) Options granted Weighted-average Remaining Contractual Life (years) Options Forfeited options Weighted-average Remaining Contractual Life (years) Options Exercised Weighted-average Remaining Contractual Life (years) Outstanding, Ending Warrant Outstanding, Beginning Warrant Outstanding, Warrants issued Warrant Outstanding, Expired Warrant Outstanding, Forfeited warrants Warrant Outstanding, Exercised Warrant Outstanding, Ending Weighted Average Exercise Price, Beginning Weighted Average Exercise Price, Warrant issued Weighted Average Exercise Price, Expired Weighted Average Exercise Price, Forfeited warrants Weighted Average Exercise Price, Exercised Weighted Average Exercise Price, Ending Weighted Average Fair Value, Beginning Weighted Average Fair Value, Warrant issued Weighted Average Fair Value, Expired Weighted Average Fair Value, Forfeited warrants Weighted Average Fair Value, Exercised Weighted Average Fair Value, Ending Weighted-average Remaining Contractual Life (Years), Beginning Weighted-average Remaining Contractual Life (Years), Warrants issued Weighted-average Remaining Contractual Life (Years), Exercised Weighted-average Remaining Contractual Life (Years), Ending Total Statistical Measurement [Axis] Accrued royalties Increase in Royalties Payable, per month Due to related party Lease term Area of land Payments for rent Lease expiration date Rent expenses Remainder of 2020 2021 2022 2023 2024 Total Stock issued for exercise of warrants. Stock issued for exercise of warrants, shares. Stock issued during pPeriod value preferred stock. Stock issued during period shares preferred stock. Joint Venture Agreement [Member] Series A Convertible Preferred Stock [Member] Two Indivuduals [Member] Professional Services Agreements [Member] Three Companies [Member] Two Companies [Member] Conversion of preferred stock, price per shares. Stock issued during period, value warrant options exercised. Purchase price. 2015 Long-term Incentive Plan [Member] Stock Options [Member] Adjusted to Issuance of Equity [Member] Sales and Marketing [Member] Repurchasing Of Market Licensing Agreement [Member] Four Companies [Member] One Company [Member] Share based compensation arrangement by share based payment award equity instruments other than options exercised weighted average grant date fair value. Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Weighted-average Remaining Contractual Life (years) Options granted. Weighted-average Remaining Contractual Life (years) Options Forfeited options. Weighted average price at which grantees can acquire the shares reserved for issuance under the non-option plan. Share-based compensation arrangements by share-based payment award, non-options, grants in period, weighted average exercise price. Weighted average price at which grantees could have acquired the underlying shares with respect to non-options of the plan that expired. Weighted average price at which grantees could have acquired the underlying shares with respect to non-options that were terminated. Share-based compensation arrangements by share-based payment award, non-options, exercise in period, weighted average exercise price Weighted average price at which grantees can acquire the shares reserved for issuance under the non-option plan. Share-based compensation arrangement by share-based payment award, non-option, weighted average exercise price Share-based compensation arrangement by share-based payment award, non-option, granted in period, weighted average exercise price. Share-based compensation arrangement by share-based payment award, non-option, expirations, weighted average exercise price. Share-based compensation arrangement by share-based payment award, non-option, forfeitures, weighted average exercise price. Share-based compensation arrangement by share-based payment award, non-option, exercise in period, weighted average exercise price. Share-based compensation arrangement by share-based payment award, non-options, outstanding, weighted average remaining contractual term. Share-based compensation arrangement by share-based payment award, non-options, granted in period, weighted average remaining contractual term. Share-based compensation arrangement by share-based payment award, non-options, exercise in period, weighted average remaining contractual term. Share-based compensation arrangement by share-based payment award, non-options, outstanding, weighted average remaining contractual term. 2020 [Member] 2021 [Member] Dr. Satterfield [Member] Exclusive License Agreement [Member] Dr. Brent Satterfield [Member] Convertible Preferred Stock [Member] Proceeds from exercise of options and warrants. Inventory moved to property, plant and equipment. Issuance of Common Stock for option and warrant exercises. Issuance of Common Stock for option and warrant exercises, shares Outstanding Options [Member] Outstanding Warrants [Member] Four Individuals [Member] Ten Employees and Two Member of Board of Directors [Member] Professional Services Agreement [Member] Weighted-average Remaining Contractual Life (years) Options Exercised. 2022 [Member] Common Stock [Member] Public offering costs. Net proceeds from issuance of common stock. Share-based Compensation Arrangement by Share-based Payment Award, Options and Warrants, Exercises in Period, Intrinsic Value. ConvertiblePreferredStocksMember CommonStockOneMember Assets, Current Assets, Noncurrent Assets Liabilities, Current Liabilities, Noncurrent Liabilities Stockholders' Equity Attributable to Parent Liabilities and Equity Gross Profit Operating Expenses Operating Income (Loss) Interest Expense, Other Other Nonoperating Income (Expense) Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Gain (Loss) on Sale of Equity Investments Increase (Decrease) in Accounts Receivable Increase (Decrease) in Prepaid Expense and Other Assets Increase (Decrease) in Inventories Increase (Decrease) in Deferred Income Taxes Net Cash Provided by (Used in) Operating Activities Payments to Acquire Property, Plant, and Equipment Payments to Acquire Interest in Joint Venture Net Cash Provided by (Used in) Investing Activities Payments of Stock Issuance Costs Net Cash Provided by (Used in) Financing Activities Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations Shares, Outstanding Inventory, Policy [Policy Text Block] Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonOutstandingWeightedAverageExercisePrice SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsWeightedAverageGrantDateFairValue Lessee, Operating Lease, Liability, to be Paid